Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure. Voprosy onkologii, v. 71, n. 5, p. OF-2520, 5 Nov.2025.